So my friend, Justin Morgenstern recently put up a post on Idarucizumab, aka Praxbind. He seemed pretty fired up on the issue, so I got him on the line to talk about it. What follows is a conversation on evidence and what to do when there is not a good amount of it.
Justin Wrote an Additional Post after our Discussion
On to the Wee…
Latest posts by Scott Weingart (see all)
- EMCrit Wee – The Brindley Sessions – Followership - November 11, 2018
- EMCrit 236 – George Kovacs on EVLI Airway Incrementalization - October 31, 2018
- EMCrit #235 – Cardiac Arrest Science with Zack Shinar - October 17, 2018